Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Rating of “Buy” by Analysts

Shares of Simulations Plus, Inc. (NASDAQ:SLP) have earned a consensus rating of “Buy” from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $51.40.

A number of research analysts have recently issued reports on SLP shares. Stephens assumed coverage on Simulations Plus in a report on Friday, November 15th. They set an “overweight” rating and a $39.00 price target on the stock. StockNews.com downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. William Blair reissued an “outperform” rating on shares of Simulations Plus in a report on Wednesday, November 6th. Finally, BTIG Research lowered their price objective on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $27.66, for a total transaction of $553,200.00. Following the completion of the sale, the director now owns 3,462,584 shares of the company’s stock, valued at approximately $95,775,073.44. The trade was a 0.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 19.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Simulations Plus

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Tributary Capital Management LLC raised its holdings in Simulations Plus by 54.7% during the third quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock valued at $10,425,000 after acquiring an additional 115,122 shares during the period. Royce & Associates LP grew its position in shares of Simulations Plus by 28.8% during the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock worth $7,602,000 after purchasing an additional 53,092 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Simulations Plus by 10.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock valued at $20,128,000 after purchasing an additional 37,992 shares during the period. Congress Asset Management Co. lifted its holdings in Simulations Plus by 22.5% in the 3rd quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock worth $6,613,000 after purchasing an additional 37,914 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its stake in Simulations Plus by 402.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock worth $1,279,000 after purchasing an additional 32,002 shares during the period. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Performance

NASDAQ:SLP opened at $29.10 on Tuesday. The firm has a market cap of $584.47 million, a P/E ratio of 59.39 and a beta of 0.80. Simulations Plus has a fifty-two week low of $27.07 and a fifty-two week high of $51.22. The firm has a 50-day simple moving average of $29.78 and a two-hundred day simple moving average of $34.16.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. The company had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The firm’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.18 earnings per share. On average, equities research analysts predict that Simulations Plus will post 1.1 EPS for the current year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.